Skip to main content
. 2024 Mar 7;24:238. doi: 10.1186/s12877-024-04841-5

Table 2.

Characteristics of participants and non-participants in the DanACo cohort and the LiKO-15 and DiaKO-19 studies

DanACo cohort LiKO-15 study DiaKO-19 study
Participants Non-participants P-value Participants Non-participants P-value Participants Non-participants P-value
Total, n(%) 5340 (14.3) 32,104* (85.7) 2611 (13.1) 17,277 (86.9) 2729 (12.8) 18,632 (87.2)
Birth year, Mean(SD) 1954.1 (3.2) 1954.6 (3.2)  < 0.001 1954.4 (3.2) 1955.0 (3.2)  < 0.001 1953.9 (3.1) 1954.3 (3.1)  < 0.001
Conscription board examination
 Age, Mean(SD) 20.4 (2.1) 20.0 (1.8)  < 0.001 20.3 (2.0) 19.8 (1.7)  < 0.001 20.5 (2.2) 20.0 (1.9)  < 0.001
 BPP-score, Mean(SD) 46.6 (9.5) 39.8 (11.3)  < 0.001 46.2 (9.8) 38.9 (11.4)  < 0.001 47.0 (9.3) 40.6 (11.1)  < 0.001
 Educational level, n(%)  < 0.001  < 0.001  < 0.001
 Low 1492 (28.0) 15,965 (49.8) 782 (30.0) 9017 (52.2) 710 (26.0) 8904 (47.9)
 Medium 1784 (33.5) 9118 (28.4) 871 (33.5) 4856 (28.1) 913 (33.5) 5319 (28.6)
 High 2053 (38.5) 6976 (21.8) 950 (36.5) 3392 (19.7) 1103 (40.5) 4370 (23.5)
 Height, Mean(SD) 179.4 (6.7) 178.5 (7.8)  < 0.001 179.3 (7.1) 178.5 (8.6)  < 0.001 179.5 (6.4) 178.5 (6.6)  < 0.001
 Weight, Mean(SD) 69.6 (9.2) 69.1 (11.5)  < 0.001 69.0 (8.9) 68.5 (12.6) 0.012 70.3 (9.5) 69.5 (10.0)  < 0.001
Information from hospital registers
 Admission to a psychiatric ward, n(%) 112501 (21.1) 8814 (27.5)  < 0.001 863 (33.1) 8068 (46.7)  < 0.001 262 (9.6) 3007 (16.1)  < 0.001
 Charlson Comorbidity Index score, Mean(SD) 1.0 (1.7) 1.3 (2.0)  < 0.001 0.9 (1.6) 1.3 (2.1)  < 0.001 1.1 (1.7) 1.3 (1.9)  < 0.001

Abbreviations: DanACo Danish Aging and Cognition cohort, LiKO-15 Lifestyle and Cognition Follow-up study 2015, DiaKO-19 Diabetes and Cognition Follow-up study 2019, SD Standard deviation, BPP Børge Prien’s Prøve (the military intelligence test)

*3,805 non-participants from the LiKO-15 study were also invited to the DiaKO-19 study. Consequently, the total number of non-participants in the DanACo cohort (n = 37,444) is equal to the combined number of non-participants from the LiKO-15 and DiaKO-19 studies (35,909) minus the 3,805 participants that were invited twice